ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ATNF 180 Life Sciences Corporation

3.1899
-0.5151 (-13.90%)
Last Updated: 15:05:07
Delayed by 15 minutes

Period:

Draw Mode:

Volume 120,422
Bid Price 3.08
Ask Price 3.19
News (4)
Day High 3.90

Low
2.8519

52 Week Range

High
55.67

Day Low 3.07
Company Name Stock Ticker Symbol Market Type
180 Life Sciences Corporation ATNF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.5151 -13.90% 3.1899 15:05:07
Open Price Low Price High Price Close Price Prev Close
3.42 3.07 3.90 3.705
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
17,778 120,422 $ 3.36 $ 404,833 - 2.8519 - 55.67
Last Trade Time Type Quantity Stock Price Currency
15:07:43 1 $ 3.12 USD

180 Life Sciences Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
32.38M 10.02M - 0 -38.73M -3.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

180 Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATNF Message Board. Create One! See More Posts on ATNF Message Board See More Message Board Posts

Historical ATNF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.994.0853.073.66726,272-0.8001-20.05%
1 Month4.0094.753.073.79335,724-0.8191-20.43%
3 Months4.945.892.85194.171,010,475-1.75-35.43%
6 Months10.6415.71682.85195.08679,936-7.45-70.02%
1 Year55.6755.672.851913.79640,632-52.48-94.27%
3 Years89.11247.86072.851980.261,032,216-85.92-96.42%
5 Years194.94247.86072.851979.58849,113-191.75-98.36%

180 Life Sciences Description

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

Your Recent History

Delayed Upgrade Clock